Docteur Pascal Mock

Pascal MOCK, MD, MSc, studied the medicine at the medical school of the University of Geneva (Switzerland). After having practiced as obstetrician and gynecologist at the University Hospital of Geneva (HUG), he further continued a specialization in Reproductive Medicine in Paris (France) at the Antoine- Béclère Hospital concluding with a Master in Physiology of Reproduction at the Pierre et Marie Curie University (Paris VI, 1998). Back to Switzerland, he obtained the certification as specialist FMH in Reproductive Medicine in 2001 Dr Mock’s research area is human embryo implantation. Between 1999 and 2001 he was the Director of a Swiss national fund for scientific research, working on the biological activity of a new placental molecule of the insulin family (INSL4). He authored several high levels scientific publications about infertility and embryo implantation. He gave lectures at the University of Geneva.

In 2004 with the business angel Martin Velasco he founded, ANECOVA, a biotech swiss company, in order to develop his invention, a novel in vivo culture system in the field of assisted reproductive technology. His collaboration with the EPFL was  important during this creative period.  In 2009 he obtained the first baby in the world born after in vivo fertilization using this new system at the clinic des Grangettes in Geneva.